Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis
Clinical trial NCT06475495 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06475495
- Sponsor
- Charite University, Berlin, Germany
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2027-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.